Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Neoplasms 1 Mucositis 1 Lymphoma, Follicular 1 Cancer Pain 1

Interventions

Oxycodone 5 Morphine 5 nabiximols 4 Naloxone 2 Fentanyl 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 tanezumab 1 naloxegol 1 incobotulinumtoxinA 1 Water 1 Transcranial Direct Current Stimulation 1 Tapentadol 1 Sodium Bicarbonate 1 Methadone 1 Lidocaine 1 Lenalidomide 1 Ketamine 1 Inosine Monophosphate 1 Hydromorphone 1 Glucose 1 Donepezil 1 Cognitive Behavioral Therapy 1 Buprenorphine 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Cancer Pain × Buprenorphine × Clear all

NCT01809106 2015-12-24

CERP

Mario Negri Institute for Pharmacological Research

Phase 4 Completed

518 enrolled 11 charts

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡